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A 51-year-old female had been diagnosed with a hemangioma in the hepatic segment 6 (S6). After a 6-year
follow-up, enlargement of the tumor was detected. The tumor was clearly enhanced in the arterial phase, and the
enhancement remained in the portal phase on computed tomography (CT). Although the primary differential
diagnosis on CT was hepatocellular carcinoma (HCC), we worried about the possibility of other vessel system
tumors because the tumor remained to be enhanced at the portal phase for HCC and all tumor markers of HCC
were negative. We performed angiography to determine the tumor nature and to seek other tumors. Angiography
showed tumor stain at the hepatic S6 with an early obvious drainage vein from the tumor flowing through the
right hepatic vein into the inferior vena cava. In addition to tumor stain and the drainage vein, there were many
small poolings of contrast medium in the whole liver, which were suspected as dilatation of the hepatic peripheral
artery. We suspected the tumor as a benign tumor such as hepatocellular adenoma or focal nodular hyperplasia,
but the possibility of HCC could not be ruled out. Hepatic posterior sectionectomy was done to completely remove
the drainage vein with the tumor. Intraoperative histological examination revealed the tumor as not malignant and
not HCC. Later, immunohistochemical analysis uncovered that the tumor had high expression of HMB-45 and,
therefore, the final diagnosis was angiomyolipoma. We think that detecting an early drainage vein from the tumor
would be a key point for diagnosing hepatic angiomyolipoma.
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Angiomyolipoma (AML) is a rare benign mesenchymal
neoplasm most often arising in the kidney, and extrare-
nal AMLs are uncommon. Among these extrarenal sites,
the liver is the most common site [1]. The appearance in
other sites is extremely rare [2,3]. AML is composed of
heterogeneous mixtures of smooth muscle cells, mature
adipose tissues, thick-walled blood vessels, with occa-
sional foci of extramedullary hematopoiesis [4-8]. Histo-
logical diagnosis is performed by immunohistochemical
staining against melanoma-associated antigen (HMB-45)* Correspondence: masato@gipc.akita-u.ac.jp
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in any medium, provided the original work is p[9]. However, hepatic angiomyolipoma (HAML) has
usually been misdiagnosed as hepatocellular carcinoma
(HCC) with a frequency of more than 50% due to signifi-
cant overlap of the imaging features [10-13]. Differential
diagnosis between HAML and HCC is very important
because their prognosis is strikingly different. In some
reports, early venous drainage from the tumor is a useful
feature for differentiating HAML from HCC [14-18]. If
early venous drainage from the tumor is detected pre-
operatively, it would be helpful for diagnosing HAML.
We here report a case of HAML showing an early
venous drainage from the tumor to the hepatic vein
detected by angiography preoperatively and review the
reported cases having early venous drainage in a specialpen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Figure 2 Magnetic resonance imaging (MRI). A. In-phase image
of chemical shift T1-weighted MRI shows low intensity at the tumor
of segment 6 (arrow). B. No further decrease of signal intensity was
observed in out-of-phase image (arrow). C. T2-weighted MRI shows
high intensity (arrow). D. Diffusion-weighted imaging showed high
intensity at the tumor (arrow).
Table 1 Laboratory data on admission
WBC 2,200/mm3 ChE 338 IU/L
RBC 405 × 104/mm3 Na 142 mEq/L
Hb 12.7 g/dL K 4.0 mEq/L
Ht 38.3% Cl 103 mEq/L
Plt 16.6 × 104/mm3 Ca 9.6 mg/dL
AST 17 IU/L CRP 0.02 mg/dL
ALT 14 IU/L Glucose 88 mg/dL
ALP 223 IU/L HbA1c 5.1%
LDH 144 IU/L CEA 2.6 ng/mL
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Case presentation
A 51-year-old female had a medical checkup by a neigh-
boring hospital, and ultrasonography (US) detected a
tumor of 9.5 mm in diameter in the posterior segment 6
(S6) of the liver. Abdominal computed tomography (CT)
detected a tumor at S6, and it had been diagnosed as
hemangioma. She was subsequently followed up by CT
every year. During the 4 years after the first diagnosis, al-
though the tumor was slightly enlarged to 20 mm in dia-
meter, the diagnosis by US and CT was still hemangioma.
However, in the next 2 years, the tumor growth was accel-
erated and had grown to 30 mm in diameter. Furthermore,
on dynamic CT image, the tumor was well enhanced by
contrast medium in the arterial phase (Figure 1A) and
remained to be enhanced in the portal phase (Figure 1B).
In-phase image of chemical shift T1-weighted MRI
showed low intensity at the tumor of S6 (Figure 2A). No
further decrease of signal intensity was observed in out-of-
phase image (Figure 2B). T2-weighted MRI showed high
intensity (Figure 2C) at the tumor. These findings sug-
gested less possibility that the tumor had fat component as
usual in AML. Diffusion-weighted imaging (DWI) showed
high intensity at the tumor (Figure 2D) and apparent diffu-
sion coefficient value was 1.57 × 10−3 mm2/s; this value
was lower than that for AML (1.92 × 10−3 mm2/s) and
higher than that for HCC (1.33 × 10−3 mm2/s) [19].
From these imagings by CT and MRI, the tumor was
rather suspected as HCC and introduced to Akita Uni-
versity Hospital. In her past medical history, she had
idiopathic thrombocytopenic purpura in pregnancy, but
it was cured without treatment. On admission, blood
examination showed slight anemia and decrease of white
blood cell count (Table 1). She was negative for hepatitis
B surface antigen and hepatitis C antibody. All serum
tumor markers of alpha-fetoprotein (AFP), AFP-L3, pro-
tein induced by vitamin K absence or antagonist-II,Figure 1 Computed tomography (CT) imaging of the abdomen.
A. There is a tumor at the segment 6 of the liver, which is well
enhanced by contrast medium at the arterial phase (arrow). B. The
tumor remains to be enhanced by contrast medium in portal
phase (arrow).
γ-GTP 30 IU/L CA19-9 17.4 U/mL
T-Bil 0.8 mg/dL AFP 3.3 ng/mL
TP 7.0 g/dL AFP-L3 0.5%
Alb 4.5 g/dL PIVKA-II 15 mAU/mL
BUN 13.5 mg/dL HBS antigen (−)
Cre 0.52 mg/dL HCV antibody (−)
AMY 332 IU/L
WBC, white blood cell; RBC, red blood cell; Hb, hemoglobin; Ht, hematocrit;
Plt, platelet; AST, aspartate aminotransferase; ALT, alanine aminotransferase;
ALP, alkaline phosphatase; LDH, lactic dehydrogenase; γ-GTP, gamma glutamyl
transpeptidase; T. Bil, total bilirubin; TP, total protein; Alb, albumin; BUN, blood
urea nitrogen; Cr, creatinine; AMY, amylase; CHE, cholinesterase; Na, sodium;
K, potassium; Cl, chloride; Ca, calcium; CRP, C-reactive protein; HbA1c,
hemoglobin A1c; CEA, carcinoembryonic antigen; CA19-9, carbohydrate antigen
19-9; AFP, alpha-fetoprotein; AFP-L3, alpha-fetoprotein fraction L3; PIVKA-II,
protein induced by vitamin K absence or antagonist-II; HBs antigen, hepatitis B
surface antigen; HCV antibody, hepatitis C virus antibody.
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19-9 were within normal limits. The indocyanine green dye
relation rate after 15 min was 2.1%, in the normal range.
We worried about the differential diagnosis between
HCC and other vessel system tumors because the tumor
remained to be enhanced at the portal phase for HCC
and all tumor markers of HCC were negative. To deter-
mine the nature of the tumor and to seek other tumors,
we performed positron emission tomography (PET) im-
aging using an 18 F-fluorodeoxyglucose (FDG) tracer and
digital subtraction abdominal angiography (DSA). There
was no hot accumulation of FDG to the tumor, and the
lesion was rather cold. DSA showed a tumor stain at the
hepatic S6 (Figure 3A). We detected further an early
drainage vein from the tumor flowing through the
right hepatic vein into the inferior vena cava (IVC)
(Figure 3A,B,C). In addition to tumor stain and drainage
vein from the tumor, there were scattered many small
poolings of contrast medium in the whole liver, which
were suspected as dilatation of the hepatic peripheral
artery (Figure 3C). Figure 3D shows the drainage vein
from the tumor in the image of CT during arterial angi-
ography. Because of the reason of the strange pattern ofFigure 3 Digital subtraction angiography (DSA) and reconstructed imag
shows a tumor stain (arrow) at the hepatic segment 6 with bold feeding arte
phase. B. Blood flow of drainage vein is gradually clear (arrow). C. Contrast me
small poolings of enhanced medium, which are suspected as peripheral bloo
image of computed tomography during arterial angiography. There is an effepoolings of contrast medium in the tumor, we suspected
the tumor as a benign tumor such as hepatocellular ad-
enoma or focal nodular hyperplasia although the possi-
bility of HCC could not be ruled out yet. Although the
preoperative biopsy was a diagnostic method of choice,
she did not desire it because of the complication risk
and the possible surgery when the result was ambiguous.
Furthermore, we had an experience of an atypical liver
hemangioma - the present patient was also followed up
for 6 years with a diagnosis of hemangioma - with an ar-
teriovenous shunt in which the patient developed heart
failure due to massive cardiac load [20].
We performed posterior sectionectomy by a Glissonean
pedicle transection method for several reasons: the tumor
location was near the Glissonean bifurcation to S6 and S7,
the volume of S7 was relatively small, and to remove the
abnormal drainage vessel which runs between the S6 and
S7. The liver looked normal macroscopically and neither
other tumors nor small hemangiomas were recognized in
the liver except the known simple liver cyst. We served
several drainage vessels into the right hepatic vein, but we
could not clearly specify which was the early drainage vein
of discussion. Interruption of feeding inflow to the tumore of computed tomography during angiography. A. Angiography
ry. An early drainage vein from the tumor is detected at hepatic arterial
dium flows intensely into inferior vena cava (arrows). There were many
d dilatation, around the whole liver. D. Three dimension reconstructed
rent vessel from the tumor (arrow).
Figure 4 Gross and histological findings. A. The resected fresh specimen showed dark yellowish soft tumor, measuring 31 mm in diameter,
with no capsule, and a small amount bleeding on the cutting surface. A neighboring small mass of 6.5 mm in diameter existed (arrow).
B. Histological examination revealed that the tumor showed that there were many epithelioid myoid cells, epithelioid clear cells with sinusoidal
vessels, and mature adipose tissues (H & E staining, objective; ×40). C. Immunohistochemical analysis revealed that epithelioid myoid cells
showed high expression of HMB-45 (objective; ×40). D. Many capillaries positive for CD34 antigen had grown (objective; ×20). E. The Ki67 index
was 0.3% (objective; ×40). F. The tumor cells were negative for c-kit (CD117), and only plasma cells were positive (objective; ×20). G. Expression
of TSC1/hamartin reduced in comparison with surrounding liver tissue (tumor; left lower, normal liver; right upper, objective; ×20). H. Elastica-
Masson stain. Tumor infiltrated into hepatic veins (objective; ×4).
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age vein inconspicuous. Intraoperative histological exam-
ination revealed that the tumor was not malignant and
not HCC. The resected fresh specimen showed dark
yellowish soft tumor, measuring 31 mm in diameter, with
no capsule, and a small amount bleeding on the cutting
surface. There existed a neighboring small mass of
6.5 mm in diameter (Figure 4A). Histological examination
showed that the tumor consisted of many epithelioid
myoid cells, epithelioid clear cells with sinusoidal vessels,
and mature adipose tissues (Figure 4B). A distinctive cap-
sule did not exist, and the tumor infiltrated into surroun-
ding normal liver tissues. Immunohistochemical analysis
uncovered that the epithelioid myoid cells expressed
HMB-45 strongly (Figure 4C). Immunoreactive proteins
for cytokeratin AE1/AE3, AFP, desmin, S100 protein, and
CD68 were all negative. Many capillaries positive for
CD34 antigen has grown (Figure 4D). The Ki67 index was
only 0.3% (Figure 4E), and tumor cells were negative for
c-kit (CD117) (Figure 4F). Expression of tuberous sclerosis
complex (TSC) 1/hamartin, a protein encoded by the
TSC1 gene, was reduced in the tumor in comparison to
the surrounding liver tissue (Figure 4G). Final diagnosis
was AML. The tumor infiltrated into the hepatic veins
(Figure 4H). There were neither other tumors nor he-
mangioma in the surrounding normal liver tissue, where
many small poolings of contrast medium were detected
on angiography. Nineteen months had passed after sur-
gery; no new lesions were detected on CT.
Discussion
In the literature describing the preoperative diagnosis of
HAML [10,13,21-25], the findings are as follows: (1)
hypervascular imaging; (2) fatty component on CT, MRI,
and US, which shows hyperechoic lesion on US, low
attenuation with a density of less than −20 Hounsfield
units on CT, and hyperintensity on both T1- and T2-
weighted sequences of MRI; (3) positive actin and HMB-45
stains on biopsy specimen. However, differential diagnosis
of HAML from other fat-containing lesions of the liver,Table 2 Reported cases having early drainage vein in hepatic
Author Publish year Number of c
1. Murakami [14] 1993 1
2. Yoshimura [15] 2002 2
3. Zheng [16] 2005 2
4. Jeon [17] 2010 5
5. Iwao [26] 2014 4
6. Wang [19] 2014 16
7. Present case 1
DSA, digital subtraction angiography; CED, contrast-enhanced Doppler; US, ultrasou
imaging,
aDrainage to hepatic vein, inferior vena cava, or portal vein.especially HCC with fatty metamorphosis, is very difficult
[13]. The proportion of fatty tissue in HAML varies
greatly, ranging from 5% to 90% [24]. This variety would
influence the images of MRI. In the present case, both in-
phase and out-of-phase images showed similar low inten-
sity, probably due to non-rich fat component and made
our diagnosis shift to other tumors than HAML. In fact,
misdiagnosis occurs at a frequency of more than 50% due
to a significant overlap of the features of imaging in
HAML and HCC [10-13]. Other tumors abounding with
blood vessels, such as hemangioma, focal nodular hyper-
plasia, or hepatic adenoma, showing resembling imaging
features, are also difficult in differential diagnosis.
Unlike these similar imaging features, a presence of an
early drainage vein has been recently focused in some
reports. In the present patient, we could observe an
extra-tumoral streak drainage vein toward the right hep-
atic vein from a thick enhanced tumor with clear margin
in DSA and an arterial phase of dynamic MDCT. To the
best of our knowledge, in English literature so far, at
least 14 patients of HAML have been reported to have
early drainage veins connecting to hepatic veins (Table 2)
[14-17,19,26]. Iwao et al. reported five cases of HAML,
and four patients (80%) had an early drainage vein flo-
wing to the hepatic vein [26]. Jeon et al. reported the
study of the presence of efferent vessels between fat-
deficient HAML (ten patients) and HCC (29 patients)
using triple-phase dynamic CT or multi-detector com-
puted tomography (MDCT) [17]. In their report, an
early drainage vein that flows into the hepatic vein was
considered to be positive in 50% with HAML. On the
other hand, in HCC patients, it was only 7%. Although
the report of Wang et al. might contaminate patients
with arterioportal (AP) shunting in their series, they re-
ported similar percentages - 16 of 22 for HAMLs
(72.7%) (obviously or at least faintly) and 2 of 25 in
HCCs (8%). Compared to HAML, the drainage vein of
HCC was faint and negligible. In HAML, an early drain-
age vein was present even in a small tumor, the size of
which was 2 cm in diameter. Meanwhile, the size ofangiomyolipoma
ases Detection modality Drainage vein
DSA Hepatic vein
DSA Hepatic vein





nd; MDCT, multi-detector computed tomography; MRI, magnetic resonance
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meter. It means that in comparison with HCC, the
drainage vein would be found in a considerable number
of HAMLs while the tumor size is still small. Thus, the
presence of early drainage vein is anticipated as a useful
feature for distinguishing HAML from HCC.
Here, we must be careful for an AP shunting that is
often seen in angiogenic liver tumors. The AP shunts
are reportedly rather frequently found in hemangiomas
as well, especially in that with rapid enhancement [27].
They are, however, usually depicted as a wedge-shaped
or irregularly shaped parenchymal fuzzy enhancement
adjacent to the tumor in the hepatic arterial phase of dy-
namic CT. This CT feature is different from that of the
early drainage vein discussed above and may be useful to
distinguish them. Although rare, there are some reports
of HAMLs with occasional association of AP shunts, too
(one case reported by Saito et al. [18] and three cases by
Jeon et al. [17]). But it is necessary to differentiate AP
shunts from the early drainage vein. Concerning the
detection modality for an early drainage vein, the useful-
ness of dynamic MDCT is reported [17,18]. In our case,
we first noticed the drainage vein during angiography,
but careful image reading of dynamic MDCT could con-
firm it.
Regarding the multiple small poolings of contrast
medium scattered in the whole liver during angiography
in our patient, the similar phenomenon has been re-
ported [16]. The lesions of the case report were diag-
nosed as multiple hemangiomas by surgery, but in our
patient, the liver looked normal macroscopically and no
hemangiomas were detected in the resected specimen
either macroscopically or histopathologically. In addition,
we could not find any micro HAML or the lesion that
might be tentatively expressed as a bud of HAML. There-
fore, it may be too hasty to conclude that these multiple
small poolings of contrast medium are indubitably small
hemangiomas. AML occurs frequently in the kidney,
where it is closely related to tuberous sclerosis [28,29].
Tuberous sclerosis is an autosomal dominant genetic
disorder that arises from germ line mutations in TSC1 or
TSC2, which encode hamartin and tuberin, respectively
[30,31]. In tuberous sclerosis patients, abnormality in
blood vessels occasionally happens, such as aneurysms or
narrowing of blood vessels. Therefore, we examined the
expression of TSC1/hamartin in the tumor in the protein
level immunohistochemically to address the mystery of
the multiple small poolings of contrast medium. The ex-
pression of TSC1/hamartin was reduced in the tumor tis-
sue in comparison with the surrounding liver tissue. This
result might show a possible relationship of the HAML
tumor with decreased TSC1/hamartin expression in this
patient but did not answer the abnormal poolings of con-
trast medium in the surrounding liver tissue duringangiography. Close follow-up of the patient for the recur-
rence of nodules is required, and the reproducibility of the
same abnormal poolings in future imagings is intriguing.
Lastly, there are some reports of malignant HAML.
Deng et al. reported malignant characteristics as marked
cell atypia, vascular invasion, high proliferation activity
(Ki67 index above 30%), and large tumor size [32]. In the
present case, precise pathological examination revealed a
tumor infiltration into the hepatic vein although the
tumor was negative for FDG-PET and low in the Ki67
index. It is uncertain whether this finding of vascular inva-
sion directly suggests the malignant transformation of this
tumor or not [33], but preoperative detection of such a
minute finding is dubious even by means of biopsy. Con-
servative management of the tumor that is diagnosed as
HAML should be careful and will be recommended only
in the condition of close follow-up, otherwise surgical re-
section is recommended.
Conclusions
We presented a case of HAML with early drainage vein
flowing to the hepatic vein. We think that detecting an
early drainage vein would be a key to diagnose the
HAML. In case an obvious drainage vein is detected,
HALM will come to the very front line of differential
diagnosis.
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